{"id":"https://openalex.org/W7053025656","doi":null,"title":"Structural analysis of SARS-CoV-2 neutralization by a spike-targeting antigen-binding fragment from a patient-derived monoclonal antibody","display_name":"Structural analysis of SARS-CoV-2 neutralization by a spike-targeting antigen-binding fragment from a patient-derived monoclonal antibody","alternate_titles":[],"publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W7053025656"},"language":"en","primary_location":{"id":"pmh:oai:helda.helsinki.fi:10138/344865","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10138/344865","pdf_url":null,"source":{"id":"https://openalex.org/S4406922691","display_name":"Helda - University of Helsinki Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"pro gradu -tutkielmat"},"parent_works":[],"lineage":["https://openalex.org/W7053025656"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jayachandran, Rupesh Balaji","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jayachandran, Rupesh Balaji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9559999704360962},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8090000152587891},{"id":"https://openalex.org/keywords/fab-fragment","display_name":"Fab fragment","score":0.7210000157356262},{"id":"https://openalex.org/keywords/spike-protein","display_name":"spike protein","score":0.734000027179718},{"id":"https://openalex.org/keywords/receptor-binding-domain","display_name":"receptor binding domain","score":0.9950000047683716},{"id":"https://openalex.org/keywords/epitope-mapping","display_name":"epitope mapping","score":0.843999981880188},{"id":"https://openalex.org/keywords/ace2-binding-site","display_name":"ACE2 binding site","score":0.7519999742507935},{"id":"https://openalex.org/keywords/heparan-sulfate","display_name":"heparan sulfate","score":0.7480000257492065},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sars-cov-2-variants-of-concern","display_name":"SARS-CoV-2 variants of concern","score":0.800000011920929},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.5870000123977661},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/antibody-antigen-complex-structure","display_name":"antibody-antigen complex structure","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9380999803543091},{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.8676000237464905},{"id":"https://openalex.org/C1009742","wikidata":"https://www.wikidata.org/wiki/Q5333998","display_name":"Ectodomain","level":3,"score":0.7423999905586243},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7239999771118164},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6251000165939331},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6223000288009644},{"id":"https://openalex.org/C2781241564","wikidata":"https://www.wikidata.org/wiki/Q1347450","display_name":"Epitope mapping","level":4,"score":0.6074000000953674},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5835999846458435},{"id":"https://openalex.org/C2776403692","wikidata":"https://www.wikidata.org/wiki/Q898416","display_name":"Trimer","level":3,"score":0.4562999904155731},{"id":"https://openalex.org/C78598654","wikidata":"https://www.wikidata.org/wiki/Q17140316","display_name":"Linear epitope","level":4,"score":0.4372999966144562},{"id":"https://openalex.org/C2780632150","wikidata":"https://www.wikidata.org/wiki/Q5160267","display_name":"Conformational epitope","level":4,"score":0.413100004196167},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4108999967575073},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.37450000643730164},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.3248000144958496},{"id":"https://openalex.org/C47701112","wikidata":"https://www.wikidata.org/wiki/Q735188","display_name":"Protein structure","level":2,"score":0.3107999861240387},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.30079999566078186},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3005000054836273},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.2870999872684479},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.2867000102996826},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.2856000065803528},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27549999952316284},{"id":"https://openalex.org/C2777648638","wikidata":"https://www.wikidata.org/wiki/Q57751738","display_name":"Coronavirus","level":5,"score":0.26919999718666077},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.2662999927997589},{"id":"https://openalex.org/C2909223937","wikidata":"https://www.wikidata.org/wiki/Q909628","display_name":"Immunoglobulin Fab Fragments","level":5,"score":0.2630999982357025},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.2596000134944916}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:helda.helsinki.fi:10138/344865","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10138/344865","pdf_url":null,"source":{"id":"https://openalex.org/S4406922691","display_name":"Helda - University of Helsinki Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"pro gradu -tutkielmat"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3046621022","https://openalex.org/W3036529319","https://openalex.org/W3044050454","https://openalex.org/W3205782097","https://openalex.org/W3035950190","https://openalex.org/W3120667919","https://openalex.org/W3036607916","https://openalex.org/W4205899851","https://openalex.org/W4392232137","https://openalex.org/W3014656992"],"abstract_inverted_index":{"COVID-19":[0,101],"pandemic,":[1],"caused":[2],"by":[3,109,229,234],"the":[4,30,58,64,70,76,86,111,120,139,148,156,175,183,193,200,209,222,236,254,276,279,301],"severe":[5,26],"acute":[6],"respiratory":[7],"syndrome":[8],"coronavirus":[9],"2":[10],"(SARS-CoV-2),":[11],"has":[12],"thus":[13],"far":[14],"claimed":[15],"over":[16],"six":[17],"million":[18],"lives.":[19],"Vaccines":[20],"against":[21],"SARS-CoV-2":[22,83,108,124,217,265],"have":[23],"successfully":[24],"mitigated":[25],"disease":[27],"and":[28,45,143,167,178,233,290,312],"eased":[29],"burden":[31],"on":[32,82],"healthcare":[33],"systems.":[34],"Neutralizing":[35,54],"antibodies":[36,55],"play":[37],"crucial":[38],"roles":[39],"both":[40,165],"in":[41,50,69,103,192,221,287,298],"vaccine":[42],"derived":[43],"immunity,":[44],"as":[46],"drugs":[47],"widely":[48],"utilized":[49],"monoclonal":[51],"antibody":[52],"therapy.":[53],"primarily":[56],"target":[57],"spike":[59,112,125,176],"protein,":[60],"where":[61],"most":[62],"of":[63,78,88,119,141,151,155,170,174,216,250,258,264,315],"neutralizing":[65,218],"epitopes":[66,219],"are":[67],"located":[68,198,220],"receptor":[71],"binding":[72,202,256],"domain":[73],"(RBD).":[74],"Elucidating":[75],"sites":[77],"vulnerability":[79],"to":[80,137,144,164,213,241,270,308],"neutralization":[81,149],"can":[84,106,162],"facilitate":[85],"development":[87],"therapeutics.":[89],"7A12":[90,122,142,161,180,188,210,226,251,305],"is":[91,196,306],"a":[92,100,117,261],"newly-discovered":[93],"IgG":[94],"antigen-binding":[95],"fragment":[96],"(Fab)":[97],"isolated":[98],"from":[99,239],"patient":[102],"Finland":[104],"that":[105,159,187,208,225,304],"neutralize":[107,228,309],"targeting":[110],"protein.":[113],"In":[114],"this":[115],"thesis,":[116],"complex":[118,157],"Fab":[121,160,179],"with":[123,253],"ectodomain":[126],"trimer":[127,177],"was":[128],"studied":[129],"using":[130],"cryogenic":[131],"electron":[132],"microscopy":[133],"(cryo-EM)":[134],"single-particle":[135],"analysis":[136],"elucidate":[138],"epitope":[140,191,211,252,302],"gain":[145],"insight":[146],"into":[147,182],"mechanism":[150],"7A12.":[152],"Cryo-EM":[153],"data":[154],"revealed":[158,247],"bind":[163],"\u201copen\u201d":[166],"\u201cclosed\u201d":[168],"conformations":[169],"RBD.":[171],"Rigid-body":[172],"fitting":[173],"models":[181],"cryo-EM":[184],"density":[185],"indicates":[186],"recognizes":[189],"an":[190,248],"RBD":[194,238],"which":[195,267,281],"mainly":[197],"outside":[199],"ACE2":[201,232],"site.":[203],"Together,":[204],"these":[205],"results":[206,246],"suggest":[207],"belongs":[212],"class":[214],"III":[215],"RBD,":[223],"indicating":[224,303],"could":[227],"sterically":[230],"hindering":[231],"preventing":[235],"adjacent":[237],"changing":[240],"\u201dup\u201d":[242],"conformation.":[243],"Furthermore,":[244],"our":[245],"overlap":[249],"putative":[255],"site":[257],"heparan":[259],"sulfate,":[260],"host":[262],"factor":[263],"infection,":[266],"might":[268],"contribute":[269],"neutralization.":[271],"7A12-RBD":[272],"interface":[273],"mapping":[274],"delineated":[275],"residues":[277],"comprising":[278],"epitope,":[280],"do":[282],"not":[283],"include":[284],"mutants":[285,295],"found":[286,297],"Beta,":[288,310],"Gamma,":[289,311],"Delta":[291,313],"variants,":[292],"while":[293],"four":[294],"were":[296],"Omicron":[299],"within":[300],"likely":[307],"variants":[314],"concern.":[316]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7053025656","counts_by_year":[],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2025-10-10T00:00:00"}
